Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/C8AF34B8.svg?ark=w1%2F20260515%2FC8AF34B8)](https://nobleid.org/work/w1/20260515/C8AF34B8)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors